SCHEMBL8899486

SCHEMBL8899486

CCN(CC)C(C)Oc1ccccc1C(=C(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 2/20 0.43
▸ ADRA2B P18089 2/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ KCNH2 Q12809 2/20 0.43
▸ PGR P06401 1/20 0.43
▸ HRH1 P35367 1/20 0.43
▸ ABCB1 P08183 5/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ KMT2A Q03164 5/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ SNCA P37840 2/20 0.34
▸ POLB P06746 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ TDO2 P48775 1/20 0.33
▸ LTB4R Q15722 1/20 0.33
▸ LTB4R2 Q9NPC1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9706157 0.79 ADRA2A (0.40) ADRA2AADRA2BHTR2AKCNH2PGR
SCHEMBL6673796 0.76 ESR1 (0.44) ADRA2AADRA2BHTR2AKCNH2PGR
SCHEMBL3805684 0.75 KDM4E (0.57) ADRA2AADRA2BHTR2AKCNH2PGR
SCHEMBL3500698 0.75 SGMS2 (0.52) NPC1KMT2AMEN1POLBNPSR1
Acetic Acid SCHEMBL29011401 0.73 KDM4E (0.58) ADRA2AADRA2BHTR2AKCNH2PGR
SCHEMBL11600086 0.73 CA12 (0.48) ADRA2AADRA2BKMT2AMEN1HTT
SCHEMBL6032890 0.71 ESR1 (0.56) ADRA2AADRA2BHTR2AKCNH2PGR
SCHEMBL15570846 0.71 ESR1 (0.56) ADRA2AADRA2BHTR2AKCNH2PGR
Acetic Acid SCHEMBL28318749 0.71 TSHR (0.57) ADRA2AKMT2AMEN1POLBNPSR1
SCHEMBL8899490 0.71 KDM4E (0.64) ADRA2AADRA2BHTR2AKCNH2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665780-A DEACTIVATING P-GLYCOPROTEIN PUMP IN TUMORS; CANCER TREATMENT MERRELL PHARMACEUTICALS INC. (US) 1997-09-09 — — US claimed
EP-0624090-B1 REVERSAL OF MULTI-DRUG RESISTANCE BY TETRAARYLETHYLENES MERRELL PHARMA INC (US) 1996-09-18 — — EP claimed
EP-0624090-A1 REVERSAL OF MULTI-DRUG RESISTANCE BY TETRAARYLETHYLENES. MERRELL DOW PHARMA (US) 1994-11-17 — — EP claimed
WO-1993015733-A1 REVERSAL OF MULTI-DRUG RESISTANCE BY TETRAARYLETHYLENES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-08-19 — — WO claimed
US-5665780-A DEACTIVATING P-GLYCOPROTEIN PUMP IN TUMORS; CANCER TREATMENT MERRELL PHARMACEUTICALS INC. (US) 1997-09-09 — — US disclosed
EP-0624090-B1 REVERSAL OF MULTI-DRUG RESISTANCE BY TETRAARYLETHYLENES MERRELL PHARMA INC (US) 1996-09-18 — — EP disclosed
US-5523304-A Reversal of multi-drug resistance by tetraarylethylenes MERRELL PHARMACEUTICALS INC. (US) 1996-06-04 — — US disclosed
Send feedback